Synthetic DNA-encoded checkpoint inhibitor antibodies advance cancer immunotherapy

Wistar scientists and collaborators demonstrate for the first time that through engineering constructs, they can express DNA-encoded monoclonal antibodies (DMAbs) targeting CTLA-4, an important cancer checkpoint molecule that blocks anti-cancer immunity.

Top News

Ain't No God; don't even think about theism

UnFox News: not a propaganda arm of the Republican party